Showing results (301-310 of 900) with videos related to
Sort By:
Pageof 90
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|September 9, 2010
Therapeutic nuclear medicine in pediatric malignancyM Schmidt, R P Baum, T Simon, et al.Nuklearmedizin. Nuclear Medicine|October 31, 2006
[Unusual, unilateral metastasis of a prostate-carcinoma and palliative rhenium-186 pain-therapy]I Breidert-Backes, S Adams, R P Baum, et al.Theranostics|April 21, 2020
Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with 177Lu-PSMA radioligand therapyFinn Edler von Eyben, Harshad R Kulkarni, Richard P BaumClinical Nuclear Medicine|August 7, 2018
Ten-Year Survival After Peptide Receptor Radionuclide Therapy of a Metastatic Well-differentiated G3 Pancreatic Neuroendocrine NeoplasmJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.Nuklearmedizin. Nuclear Medicine|August 1, 1993
[Diagnosis of thrombosis with a murine anti-thrombocyte antibody (99mTc-BW 4): initial clinical results]A Hertel, R P Baum, T Baew-Christow, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|July 24, 2001
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRIT Stuckensen, A F Kovács, S Adams, et al.Clinical Nuclear Medicine|January 24, 2019
Delayed Response (Partial Remission) 3 Years After Peptide Receptor Radionuclide Therapy in a Patient Participating in the NETTER-1 TrialJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.Clinical Nuclear Medicine|January 25, 2020
Successful Intra-arterial Peptide Receptor Radionuclide Therapy of DOTATOC-Negative High-Grade Liver Metastases of a Pancreatic Neuroendocrine Neoplasm Using 177Lu-DOTA-LM3: A Somatostatin Receptor AntagonistJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.Clinical Nuclear Medicine|March 27, 2020
177Lu-DOTATOC Peptide Receptor Radionuclide Therapy in a Patient With Neuroendocrine Breast Carcinoma and Breast Invasive Ductal CarcinomaQingxing Liu, Jingjing Zhang, Harshad R Kulkarni, et al.Revue Neurologique|April 15, 2008
[Primary brain stem hemorrhage: retrospective study of 25 cases]J S Raison, G Bourbotte, T P Baum, et al.Pageof 90